Assyro AI

FDA Orange Book · active-ingredient family

Ammonium lactate

Ammonium lactate is approved as 2 brand and 8 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:LAC-HYDRIN · NDA 020508

2

Brand (NDA)

8

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, lotion

ProductApplicantApplicationTEApproved
LAC-HYDRINRLDSUN PHARM INDS INCNDA 020508Aug 29, 1996
LAC-HYDRINRLDSUN PHARM INDS INCNDA 019155Apr 24, 1985

Generic (ANDA) products (8)

ProductApplicantApplicationTEApproved
AMMONIUM LACTATEZYDUS LIFESCIENCESANDA 217758ABMay 15, 2026
AMMONIUM LACTATEZYDUS LIFESCIENCESANDA 217815ABFeb 12, 2026
AMMONIUM LACTATEWATSON LABS INCANDA 076829Feb 07, 2006
AMMONIUM LACTATEPADAGIS ISRAELANDA 075570ABJun 23, 2004
AMMONIUM LACTATESUN PHARMA CANADAANDA 076216ABMay 28, 2004
AMMONIUM LACTATESUN PHARMA CANADAANDA 075883ABApr 10, 2003
AMMONIUM LACTATEWATSON LABS INCANDA 075575Jun 11, 2002
AMMONIUM LACTATEPADAGIS ISRAELANDA 075774ABMay 01, 2002

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ammonium lactate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.